India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...
from NDTV News - Topstories https://ift.tt/3bqUqQ1
https://ift.tt/eA8V8J
Tuesday, May 12, 2020
Home »
» India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug






0 comments:
Post a Comment